Rabies immunisation – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Thu, 28 May 2026 11:28:16 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Rabies immunisation – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Pain and Usability of Rabies Vaccine Injection Techniques in Children Aged 4-14 Using Inactivated Rabies Virus (Strain Flury LEP) https://clinicaltrials.eu/trial/study-on-pain-and-usability-of-rabies-vaccine-injection-techniques-in-children-aged-4-14-using-inactivated-rabies-virus-strain-flury-lep/ Wed, 29 Apr 2026 15:05:36 +0000 https://clinicaltrials.eu/trial/study-on-pain-and-usability-of-rabies-vaccine-injection-techniques-in-children-aged-4-14-using-inactivated-rabies-virus-strain-flury-lep/ This clinical trial is focused on studying the experience of pain and the ease of use of different injection techniques and devices for administering a vaccine against rabies in children aged 4 to 14 years. Rabies is a serious disease caused by a virus that affects the brain and can be fatal if not treated promptly. The vaccine used in this study is called Rabipur, which contains an inactivated form of the rabies virus to help the body build protection against the disease.

The purpose of the study is to estimate the level of pain children feel after receiving the vaccine. The study will involve giving the vaccine using different methods, such as injecting it into the skin (intradermal) or into the muscle (intramuscular). The study will also look at how easy and safe these methods are to use. Children participating in the study will receive the vaccine and their pain levels will be measured using a special scale designed for children. Parents or guardians will also provide their observations on the child’s pain and the usability of the injection methods.

The study will monitor the children for any side effects after the vaccination and will check if the vaccine successfully helps the body produce enough antibodies to protect against rabies. The study aims to provide valuable information on the best ways to administer the rabies vaccine to children, ensuring both effectiveness and comfort.

]]> Study of Single-Dose Rabies Vaccine (Inactivated Flury LEP Strain) Immunity After Five Years: Testing Booster Response in Previously Vaccinated Adults https://clinicaltrials.eu/trial/study-on-rabies-vaccine-boostability-after-five-years-for-patients-previously-vaccinated-with-a-single-dose-of-inactivated-rabies-virus/ Wed, 29 Apr 2026 15:05:35 +0000 https://clinicaltrials.eu/trial/study-on-rabies-vaccine-boostability-after-five-years-for-patients-previously-vaccinated-with-a-single-dose-of-inactivated-rabies-virus/ This study focuses on rabies virus prevention using Rabipur, an inactive vaccine given through intramuscular injection. The vaccine contains an inactivated rabies virus strain Flury LEP and is being studied to evaluate long-term protection against viral infections.

The purpose is to assess how well the body’s immune system remembers and responds to the rabies vaccine five years after receiving a single dose. The study involves comparing the effectiveness of a single-dose vaccination approach to a traditional two-dose vaccination schedule. Participants will receive vaccine injections and have their blood tested to measure their immune response.

The study will track participants over a five-year period. During this time, participants will receive either a single dose or two doses of the vaccine initially, followed by additional doses after five years to simulate an exposure situation. The immune system’s response will be measured through blood tests that look for protective antibodies against the rabies virus.

]]>